That Dnt mean anything |
IPO !US broker is arriving. Peel back on the bench |
Looks like you might be right BH. placing at £1 though. :) |
Another placing is needed very soon , last placing money about to run out |
40p bounce bounce bounce ...buy now or wait? Set up for the convi boyz. Enjoy the bounce guys. |
 POLX Polarean Imaging 1.6p I fancy to fill the gap to 3.2p and head to 10p+. Mcap is peanuts 1/10th of AVCT and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil in 2025 Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.
Putting this UK recovery play potential on radars as used to trade at 100p and has made significant commercial progress since FDA approval.
Massive takeover target and will be sold for 20p+ share price.
1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.
APPROX 13P SHARE PRICE EQUIVALENT FOR POLX
2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M
APPROX 48P SHARE PRICE EQUIVALENT FOR POLX
3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.
APPROX 22P SHARE PRICE EQUIVALENT FOR POLX
4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout
POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice. |
"What happened to phase 1b, phase 2 etc...?"
Seem to have gone the same way as the world's greatest Covid19 test. Still don't despair as they have some new jam tomorrow stories to tell you now, pre-clinical candidates no less, they can dine out on those for another few years. |
Duds 2025 Q2! Unsure why. I.m sure the Time Lords here may know. Q2 2025 ...will mean June 30th 2025 at the very earliest. TARDIS might need a service so not holding my breath. |
What happened to phase 1b, phase 2 etc...? |
Have U escaped a home bud? Please talk about our beloved Avacta.We are the convo Boyz na nar nar na |
VRCI 10P+ coming as well |
Where do these bots come from? Go away you vermin.Snow and nukes inbound ...so pleased I.ve bought some heated gloves and a wide compost barrel. Praise be ... |
hxxps://www.trinitydelta.org/companies/avacta/ |
Like a kangaroo this one. I think the ups and downs are ,by and large, mm.s manipulating the share price so the convis can fwd sell and then by buy back later. Mm.s don't care as long as they hit their ' turn targets' and 'convi Boyz shave'. Normal practice. Frustrating for holders who require some clarity. Have a great weekend. 2 Michelin restaurants for moi. Cartmel and Barngate. Treat! |
Along with VCP, must be the easiest and best short ever? |
Ph 1a/b ...Q2 2025. Time Lord and TARDIS booked. Hold on tight boys, clench. |
Updated presentation. |
44p next then 40p ...Daren.t look below this on the graph. Gulp. |
Oh yes, desperately trying to close their short. Gaetz for attorney general - wtf! I.ve gone short the DOW as the carnage is about to unfurl. Only for the brave. Putin/ Trump/ Xi/ Netanyahu ...dictators together ...missing Farage only now. Strap in, Whitey strap on, it.s beginning. |
POLX Polarean Imaging about to break out above 2p soon. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.55p and gap at over 3p. ATH 100p. Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.
Putting this UK recovery play potential on radars.
1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.
APPROX 13P SHARE PRICE EQUIVALENT FOR POLX
2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M
APPROX 48P SHARE PRICE EQUIVALENT FOR POLX
3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.
APPROX 22P SHARE PRICE EQUIVALENT FOR POLX
4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout
POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice. |
GSA Short desperately trying to close, but every time they try; the price spikes. Poor things. Lol |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
